| __timestamp | PTC Therapeutics, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 152500000 |
| Thursday, January 1, 2015 | 121816000 | 187800000 |
| Friday, January 1, 2016 | 117633000 | 184000000 |
| Sunday, January 1, 2017 | 117456000 | 167700000 |
| Monday, January 1, 2018 | 171984000 | 218600000 |
| Tuesday, January 1, 2019 | 257452000 | 187400000 |
| Wednesday, January 1, 2020 | 477643000 | 177700000 |
| Friday, January 1, 2021 | 540684000 | 122000000 |
| Saturday, January 1, 2022 | 651496000 | 123100000 |
| Sunday, January 1, 2023 | 666563000 | 122500000 |
Unlocking the unknown
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, PTC Therapeutics, Inc. and Perrigo Company plc have demonstrated contrasting R&D investment strategies. PTC Therapeutics has shown a remarkable growth trajectory, with R&D expenses increasing by over 730% from 2014 to 2023. This surge underscores their commitment to pioneering new therapies. In contrast, Perrigo Company plc's R&D spending has remained relatively stable, peaking in 2018 and then declining by approximately 44% by 2023. This divergence highlights differing strategic priorities: PTC's aggressive pursuit of innovation versus Perrigo's focus on optimizing existing product lines. As the biopharma industry continues to advance, these investment patterns offer valuable insights into the future direction of these companies and their potential impact on healthcare.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs Perrigo Company plc
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Perrigo Company plc vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Perrigo Company plc vs MorphoSys AG
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending